NASDAQ: LTRN
Lantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?

Insider buying vs selling

Have Lantern Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
D. Jeffrey KeyserDirector2024-07-243,832$3.13
$11.99kSell
Leslie W. Kreis10% Owner2024-05-241,859$6.33
$11.77kSell
Aaron Gl Fletcher10% Owner2024-05-244,253$6.33
$26.92kSell
Aaron Gl Fletcher10% Owner2024-05-2413,888$6.33
$87.91kSell
Aaron Gl Fletcher10% Owner2024-05-241,859$6.33
$11.77kSell
Leslie W. Kreis10% Owner2024-05-244,253$6.33
$26.92kSell
Leslie W. Kreis10% Owner2024-05-2413,888$6.33
$87.91kSell
Leslie W. Kreis10% Owner2024-05-232,126$6.25
$13.29kSell
Aaron Gl Fletcher10% Owner2024-05-23930$6.25
$5.81kSell
Leslie W. Kreis10% Owner2024-05-236,944$6.25
$43.40kSell

1 of 2

LTRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTRN insiders and whales buy or sell their stock.

LTRN Shareholders

What type of owners hold Lantern Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis28.90%3,116,820$10.88MInsider
Aaron Gl Fletcher11.44%1,233,802$4.31MInsider
Bios Capital Management LP11.20%1,207,709$4.21MInstitution
David S. Silberstein9.68%1,044,000$3.64MInsider
Biological Mimetics Inc9.68%1,044,000$3.64MInsider
Arunkumar Asaithambi4.10%441,960$1.54MInsider
Vanguard Group Inc3.37%363,720$1.27MInstitution
CM Management LLC1.85%200,000$698.00kInstitution
Green Park Golf Ventures II LLC1.22%131,697$459.62kInsider
Renaissance Technologies LLC0.81%87,300$304.68kInstitution

1 of 3

LTRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTRN23.18%65.02%Net Selling
RNTX14.37%85.63%Net Selling
ANTX37.29%62.71%Net Selling
ITRM3.60%65.90%
ESLA0.81%82.00%

Lantern Pharma Stock Ownership FAQ

Who owns Lantern Pharma?

Lantern Pharma (NASDAQ: LTRN) is owned by 23.18% institutional shareholders, 65.02% Lantern Pharma insiders, and 11.80% retail investors. Leslie W. Kreis is the largest individual Lantern Pharma shareholder, owning 3.12M shares representing 28.90% of the company. Leslie W. Kreis's Lantern Pharma shares are currently valued at $10.97M.

If you're new to stock investing, here's how to buy Lantern Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.